title: Sitagliptin-induced pancreatitis - a longer road than expected.
abstract: Sitagliptin-induced pancreatitis can occur at any time after the initiation of therapy, even after several years. Patients taking sitagliptin who present with signs and symptoms of mild or severe pancreatitis should immediately discontinue sitagliptin and use an alternate medication regimen for control of type 2 diabetes.
authors.affiliation: Department of Internal Medicine- Rush University Medical Center, Roosevelt University College of Pharmacy 1400 N Roosevelt Blvd, Schaumburg, Illinois, 60173.
authors.forename: Matthew
authors.initials: M
authors.lastname: Nelson
authors.affiliation: Department of Internal Medicine, Rush University Medical Center 1653 W Congress Parkway, Jones 301, Chicago, Illinois, 60612.
authors.forename: Niyati
authors.initials: N
authors.lastname: Bhandari
authors.affiliation: Department of Internal Medicine, Rush University Medical Center 1653 W Congress Pkwy Jones 325, Chicago, Illinois, 60612.
authors.forename: Jill
authors.initials: J
authors.lastname: Wener
keywords: Sitagliptin; dipeptidyl peptidase IV inhibitor; pancreatitis; type II diabetes mellitus